1992

Foundation of the company. The development of a new multi-purpose pharmaceutical product - CYCLOFERON - which has no analogues not only in Russia, but throughout the world as well.

1993

Cycloferon was registered as a veterinary drug. The registration of Cycloferon as a medicinal product was started.

1994

"Cycloferon" received a medal of the all-Russian Exhibition Center (VDNH) for the best development in a veterinary medicine.

1995

Registration of “Cycloferon” product (solution) for medical application.

1996

Drug manufacturing licence was received for the production “Cycloferon”. POLYSAN became the first private pharmaceutical company in the country that managed to register the medicinal product of its own design and obtain a license for it!

Start of “Reamberin” medicinal product development.

1999

Registration of "Reamberin" which became the first infusion preparation based on succinic acid in the world,

a new-generation solution.

2000

Registration of “Cycloferon” medicinal product (tablets)

The Company’s management took a decision on the construction of its own plant in St. Petersburg.

2002

POLYSAN acquired an API manufacturing plant in Belgorod – “POLYSINTEZ” Ltd.

2004

Registration of “Cytoflavin” medicinal product (solution)

STPF POLYSAN was awarded the Russian Federation Government prize in science and technology "For the development, management of commercial output and introduction into medical practice of the finished dosage form of a new domestic drug Cycloferon.".

2005

First stage of the pharmaceutical plant commissioned

2006

Registration of “Cytoflavin” medicinal product (tablets)

Cycloferon was included in the federal standards of the Ministry of Public Health and Social Development of Russia on treatment of patients with chronic hepatitis B and C, tuberculosis, HIV infection and influenza.

Under the technical and scientific and methodological assistance of POLYSAN, a Russian-Lao diagnostics and treatment center on viral infections was set up. The patients’ treatment was carried out using the STPF POLYSAN pharmaceutical products.

2007

STPF POLYSAN became a laureate of the international award “PROFESSION – LIFE” for the achievements in the pharmaceuticals manufacturing, health industry and environment preservation.

STPF POLYSAN was awarded the St. Petersburg Government prize for the achievements in export activities.

At the conclusion of the international audit of the pharmaceutical plant, POLYSAN obtained an international certificate confirming the compliance of the medicinal products manufacturing and quality control management systems with the requirements of GMP EU.

2008

POLYSAN was awarded the St. Petersburg Government prize for the achievements in the products export activities (2nd place).

2009

Registration of “Remaxol” medicinal product

STPF POLYSAN became a holder of the highest award in the competition "The best exporter of St. Petersburg" among small and medium-sized enterprises - for achievements in the field of product export.

2010

STPF POLYSAN was awarded the Russian Federation Government prize in science and technology for the development

of "Cytoflavin" medicinal drug. STPF POLYSAN became a laureate of the St. Petersburg Government Award on quality, as well as the national award “GOLDEN MERCURY” in the field of entrepreneurial activity in a nomination "Best Enterprise - Exporter" in commercial manufacture for 2009.

“Cycloferon”, “Cytoflavin”, “Reamberin” were included in the List of Vital and Essential Drugs.

2011

STPF POLYSAN was awarded the status of “Attractive Employer-2011” as per the results of the study conducted by the Superjob.ru portal among companies-employers operating in Russia.

By the decision of the Legislative Assembly of St. Petersburg STPF POLYSAN was awarded an honorary diploma for its outstanding contribution to the economic development of St. Petersburg.

2011

STPF POLYSAN becomes the winner of the “GOLDEN MERCURY” national award in the field of entrepreneurial activity in a nomination "Best Enterprise - Exporter" in the field of international innovative cooperation for 2010.

2012

For the third time in its history, STPF POLYSAN won the regional stage of the national award competition in the field of entrepreneurial activity “GOLDEN MERCURY” in a nomination "Best Enterprise - Exporter" in the field of commercial manufacture for 2011.
Commencement of cooperation with the international pharmaceutical company “STADA”.

2013

Second stage of the pharmaceutical plant, modern warehouse and in-house power supply facility constructed and commissioned

STPF POLYSAN was awarded a diploma for its significant contribution to the implementation of the governmental social-economic policy in St. Petersburg.

2014

STPF POLYSAN ranked among TOP-30 largest companies as per the results of the Third National Rating of Russian technologically advanced and fast-developing companies “TechSuccess-2014”/ STPF POLYSAN was included in the non-governmental register of Russian enterprises and entrepreneurs, whose financial and economic status made them a reliabile partner for entrepreneurial activities in the Russian Federation and abroad.

2014

POLYSAN became a laureate of the contest "100 best organizations in Russia. Ecology and Environmental Management "and was awarded a golden medal, which was confirmed by a diploma and was an evidence of recognition of the company's achievements in the field of environmental protection and ecological safety of manufacturing. The company’s General Director A. A. Borisov was awarded with a badge "Environmental expert of the Year - 2014."

2015

POLYSAN took the 1st place in the nomination "Clean Waters of the Baltics." The victory in this nomination testified the implementation by STPF POLYSAN of environmental and water protection activities in full scope and on time.

POLYSAN was a laureate of the National rating of technologically advanced and fast-developing companies “TechSuccess”

2015

POLYSAN and Bayer corporate group entered into a Strategic Partnership Agreement with the purpose of manufacturing of Bayer products at POLYSAN facilities and executed a production contract. The event was designated by the expert council of the RBC Petersburg 2015 Prize as a "Deal of the Year."

2016

STPF POLYSAN and a biopharmaceutical company “Pfizer” concluded an agreement on the production of three Pfizer pharmaceutical products at the POLYAN manufacturing facilities.

POLYSAN received a "Certificate of Trust to the Employer," which indicated that the company was included in the register of employers respecting the labor and employment rights of its employees

2016

2017

The modernization and revamping project of the POLYSAN pharmaceutical plant production capacities was recognized as a strategic investment project of St. Petersburg, and POLYSAN - as a strategic investor of St. Petersburg. < br > As per the results of the audit in Chile, POLYSAN received a new GMP certificate.

2017

"Cycloferon" medicinal product received the prize "Product of the Year - 2017" in a nomination "Immunomodulators" and became one of the winners of the RUSSIAN PHARMA AWARDS ®
-2017 in a nomination "The most frequently prescribed drug in the treatment of influenza and ARVI" General Director of STPF POLYSAN A. A. Borisov was granted a title "TOP MANAGER OF THE YEAR" in “Pharmaceutical Industry”.

2018

General Director of STPF POLYSAN A. A. Borisov became one of the laureates of the contest "Environmentally Responsible Leader" in a nomination "Production and consumption wastes management."

STPF POLYSAN became a laureate of the competition "100 best organizations in Russia. Ecology and Environmental Management” in a nomination “For achievements in production and consumption wastes management.

Commissioning of the third stage of the plant - a five-storied production and laboratory complex with a total area of 9800 square meters. The project was designed in accordance with the current international and national pharmaceuticals manufacturing, quality control and storage requirements.

Production of Pfizer's pharmaceutical product “Jakvinus” for the treatment of rheumatoid arthritis was launched at STPF POLYSAN plant

2019

In accordance with the signed Strategic Partnership Agreement and the production agreement POLYSAN began to produce commercial batches of the Bayer product “Ultravist ®”.

Registration of Cytoflavin in Vietnam was successfully finalized.

POLYSAN opened its own research and development center - a unique platform for the development of innovative domestic pharmaceutical products.

2019